Such HIF-1α inhibition further suppresses hypoxia-mediated induction of monocyte chemoattractant protein-1 (MCP1), ultimately restricting the infiltration of TAMs into the tumor microenvironment and enhancing the effect of radiotherapy [166]. The gene discussed is CCL2; the disease is neoplasm.